Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 237


Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.

Paul PK, Gupta SK, Bhatnagar S, Panguluri SK, Darnay BG, Choi Y, Kumar A.

J Cell Biol. 2010 Dec 27;191(7):1395-411. doi: 10.1083/jcb.201006098.


TWEAK and TRAF6 regulate skeletal muscle atrophy.

Kumar A, Bhatnagar S, Paul PK.

Curr Opin Clin Nutr Metab Care. 2012 May;15(3):233-9. doi: 10.1097/MCO.0b013e328351c3fc. Review.


Mechanisms of skeletal muscle atrophy.

Ventadour S, Attaix D.

Curr Opin Rheumatol. 2006 Nov;18(6):631-5. Review.


Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.

Op den Kamp CM, Langen RC, Minnaard R, Kelders MC, Snepvangers FJ, Hesselink MK, Dingemans AC, Schols AM.

Lung Cancer. 2012 Apr;76(1):112-7. doi: 10.1016/j.lungcan.2011.09.012. Epub 2011 Oct 20.


Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients.

Sun YS, Ye ZY, Qian ZY, Xu XD, Hu JF.

J Exp Clin Cancer Res. 2012 Sep 26;31:81. doi: 10.1186/1756-9966-31-81.


The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms.

Paul PK, Bhatnagar S, Mishra V, Srivastava S, Darnay BG, Choi Y, Kumar A.

Mol Cell Biol. 2012 Apr;32(7):1248-59. doi: 10.1128/MCB.06351-11. Epub 2012 Jan 30.


Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.

Sandri M.

Int J Biochem Cell Biol. 2013 Oct;45(10):2121-9. doi: 10.1016/j.biocel.2013.04.023. Epub 2013 May 7. Review.


Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.

Ringseis R, Keller J, Lukas I, Spielmann J, Most E, Couturier A, König B, Hirche F, Stangl GI, Wen G, Eder K.

Biochim Biophys Acta. 2013 Jan;1830(1):2105-17. doi: 10.1016/j.bbagen.2012.09.024. Epub 2012 Oct 4.


Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.

Sandri M, Coletto L, Grumati P, Bonaldo P.

J Cell Sci. 2013 Dec 1;126(Pt 23):5325-33. doi: 10.1242/jcs.114041. Review.


Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.

Silva KA, Dong J, Dong Y, Dong Y, Schor N, Tweardy DJ, Zhang L, Mitch WE.

J Biol Chem. 2015 Apr 24;290(17):11177-87. doi: 10.1074/jbc.M115.641514. Epub 2015 Mar 18.


TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.

Bhatnagar S, Mittal A, Gupta SK, Kumar A.

J Cell Physiol. 2012 Mar;227(3):1042-51. doi: 10.1002/jcp.22821.


Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia.

Attaix D, Combaret L, Béchet D, Taillandier D.

Curr Opin Support Palliat Care. 2008 Dec;2(4):262-6.


Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.

Hindi SM, Sato S, Choi Y, Kumar A.

Hum Mol Genet. 2014 Mar 15;23(6):1492-505. doi: 10.1093/hmg/ddt536. Epub 2013 Oct 24.


Autophagic degradation contributes to muscle wasting in cancer cachexia.

Penna F, Costamagna D, Pin F, Camperi A, Fanzani A, Chiarpotto EM, Cavallini G, Bonelli G, Baccino FM, Costelli P.

Am J Pathol. 2013 Apr;182(4):1367-78. doi: 10.1016/j.ajpath.2012.12.023. Epub 2013 Feb 8.


The ubiquitin-proteasome system and skeletal muscle wasting.

Attaix D, Ventadour S, Codran A, Béchet D, Taillandier D, Combaret L.

Essays Biochem. 2005;41:173-86. Review.


IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.

Muroi M, Tanamoto K.

Biochim Biophys Acta. 2012 Feb;1823(2):255-63. doi: 10.1016/j.bbamcr.2011.10.003. Epub 2011 Oct 18.


Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.

Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N.

Circ Res. 2005 Sep 2;97(5):418-26. Epub 2005 Jul 28.


Posttranslational modifications control FoxO3 activity during denervation.

Bertaggia E, Coletto L, Sandri M.

Am J Physiol Cell Physiol. 2012 Feb 1;302(3):C587-96. doi: 10.1152/ajpcell.00142.2011. Epub 2011 Nov 16.


Molecular signaling pathways regulating muscle proteolysis during atrophy.

Franch HA, Price SR.

Curr Opin Clin Nutr Metab Care. 2005 May;8(3):271-5. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk